EYPT
Eyepoint Pharmaceuticals Inc
NASDAQ: EYPT · HEALTHCARE · BIOTECHNOLOGY
$13.20
+2.64% today
Updated 2026-04-30
Market cap
$1.08B
P/E ratio
—
P/S ratio
34.35x
EPS (TTM)
$-3.17
Dividend yield
—
52W range
$5 – $19
Volume
1.2M
Eyepoint Pharmaceuticals Inc (EYPT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-16.14M | $-21.21M | $-5.14M | $-8.44M | $9.90M | $-3.17M | $-9.00M | $-8.74M | $-10.67M | $10.30M | $-16.32M | $-20.49M | $-21.91M | $-56.70M | $-14.44M | $-50.10M | $-65.00M | $1.88M | $-126.23M | $-240.11M |
| Capital expenditures | $1.15M | $82000.00 | $272000.00 | $195000.00 | $15000.00 | $133000.00 | $405000.00 | $68000.00 | $248000.00 | $161000.00 | $113000.00 | $147000.00 | $108000.00 | $213000.00 | $362000.00 | $156000.00 | $2.15M | $3.48M | $4.05M | $3.28M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $-495687.00 | $4.84M | $-13000.00 | $1.50M | $2.05M | $1.41M | $1.32M | $1.41M | $1.96M | $2.16M | $2.46M | $2.70M | $3.97M | $4.57M | $5.55M | $7.45M | $14.18M | $12.06M | $36.74M | $27.87M |
| Free cash flow | $-17.29M | $-21.30M | $-5.42M | $-8.63M | $9.88M | $-3.30M | $-9.41M | $-8.81M | $-10.92M | $10.14M | $-16.43M | $-20.64M | $-22.02M | $-56.91M | $-14.80M | $-50.25M | $-67.16M | $-1.61M | $-130.28M | $-243.39M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | $-8.29M | $2.27M | $8.44M | $3.79M | $-3.81M | $1.58M | $21.88M | — | $-23.05M | $22.70M | $133.68M | $-82.96M | — | — | — |